SECTION 1. Low and very low birth weight infants.- 1. Development of thyroid function in very low birth weight infants -- 2. Growth after very low birth weights: Germany perspectives -- 3. First trimester fetal growth and low birth weight -- 4. Following up very low birth weight children to preschool age -- 5. Zinc and low birth weight -- 6. Early nutrition and very low birth weights infants -- 7. Aggressive nutritional strategy in very low birth weight infants: impact on growth -- 8. Visual development in very low birth weight infants -- 9. Visual ability in very low birth weight infants -- 10. Parental relationships with very low birth weight infants -- SECTION 2. Intrauterine growth retardation -- 11. Intrauterine growth standards -- 12. Risk factors for adverse outcomes in developing countries: role of interuterine growth retardation -- 13. Growth outcomes in intrauterine growth retardation: Australian perspectives -- 14. Neurodevelopment outcome of children with intrauterine growth retardation: A longitudinal, 10-year prospective study -- 15. Memory functions of children with intrauterine growth restriction -- 16. Intrauterine growth and intelligence -- 17. Drug exposure and intrauterine growth .-18. Intrauterine growth retardation and non-alcoholic fatty liver disease in children -- 19. Ultrasound brain lesions in intrauterine growth retardation -- 20. Intrauterine growth restriction and blood pressure -- 21. Treatment for Short stature after intrauterine growth retardation -- 22. Anthropometric parameters and intrauterine growth retardation: Togo perspectives .- SECTION 3. Preterm infants -- 23. Periodic breathing in term and preterm infants -- 24. The relationship between growth and perinatal factors in preterm infants -- 25. Growth curves for preterm infants -- 26. Development of oral feeding skills in the preterm infant -- 27. Growth factors and endocrine milieu in preterm and term infants -- 28. Protein metabolism in preterm infants: implications for growth -- 29. Birth weight standards, fetal growth, and preterm infants -- 30. Maturation and growth indices of the brain in preterm infants -- 31. The development of cerebral cortex in prematurely born infants -- 32. Development of motor coordination and attention in preterm infants and relation to intensive care -- 33. Inflammatory and growth mediators in the blood in preterm infants -- 34. Weight gain and linear growth in milk feeding in preterm infants -- 35. Brain volume in preterm infants -- 36. Impact of prematurity on school-age outcomes -- 37. Visual and visuocognitive development in children born very prematurely -- SECTION 4. Postnatal growth in normal and abnormal situations -- 38. Defects on long arm of chromosome 20 and postnatal growth retardation -- 39. Postnatal growth in HIV -- 40. Postnatal growth failure and Z score -- 41. Prediction of postnatal growth curves for premature infants -- 42. Adiposity during preweaning postnatal growth -- 43. Postnatal development in cleft palate -- 44. Blood pressure and postnatal growth in schoolchildren: World and Mexico perspectives -- 45. Hormonal regulation of postnatal growth in children -- 46. Postnatal growth and growth hormone -- 47. Postnatal weight increase and growth velocity of very low birth weight infants: Italian perspectives -- SECTION 5. Catch-up growth -- 48. Weight requirements for Catch-up growth in girls with eating disorders -- 49. Catch-up growth and corticosteroids -- 50. Thyroid function during Catch-up growth -- 51. Endocrine aspects of catch-up growth -- 52. Catch-up growth: Hertfordshire studies -- 53. Catch-up growth up to ten year olds: Dutch perspectives -- 54. Catch-up growth and supine length/height in preterm infants -- 55. Catch-down growth and short-statured parents -- 56. Adiposity and insulin resistance after catch-up growth -- 57. Catch-up and normal growth of children on long-term dialysis -- 58. Lung development in children and in catch-up growth -- 59. Catch-up growth in refugee children -- 60. Failure to achieve catch-up growth: Spanish studies -- 61. Catch-up growth: Mexico perspectives -- 62. Growth surveillance of those without catch-up -- 63. Serum adiponectin levels, insulin resistance, and lipid profile in catch-up and non-catch-up growth -- SECTION 6. Sexual maturation -- 64. Genital development in boys and testosterone levels -- 65. Pesticides and male genital growth -- 66. Pesticides and sexual development in girls -- 67. Disorders of breast growth -- 68. Sexual maturity in slums and rural areas -- 69. Breast development and the environment -- 70. Precocious puberty and growth of breast tissue -- 71. Gonadotropin-suppressive therapy and sexual growth -- 72. Sexual dimorphism and cortisol -- 73. Growth and sexual maturation in psychological disorders -- SECTION 7. Cells and growth of tissues -- 74. Growth and development of the brain -- 75. Growth and development of the kidney -- 76. Growth and development of the intestine -- 77. Growth and development of bone -- 78. Growth and development of muscle -- 79. Growth and development of liver -- 80. Growth and development of heart -- 81. Growth and development of dentofacial tissue -- SECTION 8. Sensory growth and development -- 82. Multisensory reweighting in children -- 83. Motor development in normal children and in disease -- 84. Speech and language development in normal children and in disease -- 85. Visual development -- 86. Development of hearing -- 87. Speech intelligibility development in hearing impaired -- 88. Development of the immune system -- SECTION 9. Country and regional aspects of growth and growth monitoring -- 89. Overview: Child development in developing countries -- 90. Rural versus urban growth in 47 developing countries -- 91. Effect of infant feeding on growth in 20 developing countries -- 92. Field-testing growth standards in different countries -- 93. Breast-feeding and growth in Lebanon -- 94. Features of normal and abnormal growth in India -- 95. Features of normal and abnormal growth in China -- 96. Features of normal and abnormal growth in Brazil -- 97. Features of normal and abnormal growth in Russia -- SECTION 10. Effects of disease on growth -- 98. Impaired bone mineral density in children with cerebral palsy -- 99. Growth in sickle cell disease -- 100. The NIH MRI study of normal brain development in the young -- 101. Minerals and growth: an example with zinc -- 102. Fetal alcohol exposure and infant growth -- 103. Iron deficiency anemia and infant growth -- 104. Growth in children with severe hemophilia -- 105. Growth in autism -- 106. Growth in Down syndrome -- 107. HIV-infected children and growth -- 108. Growth in short bowel syndrome (SBS) -- 109. Child growth and livelihood security -- 110. Growth in cerebral palsy -- 111. Growth in congenital heart disease -- SECTION 11. Exercise, sports, and growth -- 112. Elite sport practice in children: effects on growth -- 113. Effects of gymnastics on growth and pubertal maturation in young girls -- 114. Physical activity and bone growth and development in children -- 115. Child growth in physical activity skill development and dietary modification -- 116. The interaction of exercise, stress, and inflammation on growth -- 117. Growth hormone response to exercise.-118. Physical activity and bone growth -- 119. Infant mental development index -- SECTION 12. Endocrine Control and Regulation of Growth -- 120. Growth deceleration and corticosteroids -- 121. Leptin and ghrelin in growth -- 122. Insulin-like growth factor and growth.-123. Adiponectin and growth -- 124. Thyroid hormones and growth -- 125. Growth hormone and child growth -- 126. Growth hormone, Prader-Willi syndrome, and growth -- SECTION 13. Assessment of Growth -- 127. The 2006 WHO Child Growth Standards -- 128. WHO Child Growth Standards and the CDC 2000 growth charts -- 129. International growth standards for school-aged children and adolescents -- 130. Infant growth modeling and assessment of growth -- 131. Use of weight, height, and body mass index to indicate growth failure -- 132. Assessment of psychomotor development and growth -- 133. Growth and development in developing countries: what standards? .-134. Use of MRI to monitor brain growth -- 135. Neonatal screening methods -- 136. False positives and sensitivity in growth monitoring -- 137. Z scores: what they are and how to use them -- 138. Percentiles: what they are and how to use them -- 139. Growth velocity curves: what they are and how to use them.-140. Physical activity measured by accelerometry: completing growth evaluations